Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study.

Youjin Wang | Ana Best | Roberto Fernández-Torrón | Rotana Alsaggaf | Mikel Garcia-Puga | Casey L Dagnall | Belynda Hicks | Mone't Thompson | Ander Matheu Fernandez | Miren Zulaica Ijurco | Mark H Greene | Adolfo Lopez de Munain | Shahinaz M Gadalla
Annals of clinical and translational neurology | 2020

Myotonic dystrophy type I (DM1) is an autosomal dominant disease of which clinical manifestations resemble premature aging. We evaluated the contribution of telomere length in pathogenesis in 361 DM1 patients (12 with serial measurements) and 223 unaffected relative controls using qPCR assay. While no differences in baseline leukocyte relative telomere length (RTL) was noted, the data suggested an accelerated RTL attrition in DM1 (discovery cohort: T/S change/year = -0.013 in DM1 vs. -0.005 in controls, P = 0.04); similar trend was noted in validation cohort. Further investigations are needed to examine the role of TL in the pathophysiology of DM1.

Pubmed ID: 31808320

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: Intramural Research Program of the Division of Cancer Epidemiology and Genetics, International
  • Agency: NCI NIH HHS, United States
  • Agency: NIH HHS, United States
  • Agency: NCI NIH HHS, United States
  • Agency: NIH HHS, United States

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


QIAGEN (tool)

RRID:SCR_008539

A commercial organization which provides assay technologies to isolate DNA, RNA, and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis.

View all literature mentions